If you are over the age of 59, there is a 6% chance that you will develop vitamin B12 deficiency
No IGF-1 Elevation and No GH Receptor Activation As previously discussed, AOD-9604 is completely detached from the pathways that cause cellular proliferation
The key rule: never mix different peptides in the same syringe or vial
This injection is rarely fabricated and contains few chemicals
(PubMed) Termanini B, Gibril F, Sutliff VE, Yu F, Venzon DJ, Jensen RT
Safety: what we know, what we dont What clinical trial safety reviews suggest The clinical safety review literature reports several reassuring signals: No meaningful increase in IGF-1 in monitored long-term studies (jofem.org) No clear negative effect on carbohydrate metabolism in testing described (contrast with full hGH) (jofem.org) No clear immunogenicity signal (e.g., anti-AOD antibodies) in the subset assessed in those trials (jofem.org) The major limitation: long-term real-world certainty is thin The problem with many peptides is not that everything is dangerousits that the certainty level is often lower than patients assume
![Ozempic Vision Loss Lawsuit [2026 Update]](https://www.torhoermanlaw.com/wp-content/uploads/2024/09/What-To-Do-If-You-Suspect-Vision-Loss-Due-to-Ozempic-and-Other-Semaglutide-Drugs-1.jpg)
